Status:
RECRUITING
The Genetics of Pulmonary Fibrosis
Lead Sponsor:
University of Colorado, Denver
Conditions:
Idiopathic Pulmonary Fibrosis (IPF)
Eligibility:
All Genders
18+ years
Brief Summary
This study seeks to screen first degree family members of people with Idiopathic Pulmonary Fibrosis (IPF) for the earliest signs of lung fibrosis.
Detailed Description
The purpose of this study is to explore genetic factors associated with the development of pulmonary fibrosis. The investigators aim is to identify and explore genetic loci that affect development of ...
Eligibility Criteria
Inclusion
- Age at least 18 years old
- Family member diagnosed with IPF
Exclusion
- \- No family member with IPF
Key Trial Info
Start Date :
January 18 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT03478553
Start Date
January 18 2018
End Date
December 31 2026
Last Update
March 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Colorado Anschutz Medical Campus
Aurora, Colorado, United States, 80045